Company profile
Kuano
Kuano Ltd is a UK company with status active founded in 2020 based in East of England.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Sep 2023 to 28 Feb 2025
Kuano is a techbio startup dedicated to bringing the latest innovation and technology for drug discovery to the pharmaceutical industry. As part of their long term strategy to unlock currently undruggable enzymes they are developing advanced simulation approaches to target complex quantum systems. This Feasibility Study seeks to exploit novel algorithms t...
1 Dec 2022 to 31 May 2024
Bowel cancer is a leading cause of death worldwide, with 17,000 deaths each year in the UK alone. Existing therapies suffer from the development of resistance. Kuano is looking to apply an innovative combination of quantum simulation and AI to produce a new generation of drugs targeting an enzyme (NOTUM) recently discovered to play a key role in cancer de...
1 Aug 2021 to 31 Jan 2023
Kuano is a company dedicated to bringing the latest innovation and technology for drug discovery to the pharmaceutical industry. Kuano's unique approach tackles common challenges in both AI-driven drug design and target driven drug discovery. This Feasibility Study seeks to exploit second generation quantum techniques to solve currently intractable proble...
1 Jun 2020 to 31 Mar 2021
When new diseases such as COVID-19 emerge, it is not known whether existing drugs could be effective or new drugs need to be designed. The lack of information on an emerging disease makes these problems hard to solve, and it is made worse by the fact that subtle differences between diseases can have a large impact on which medicines are effective. In this...
